Europe Micro Invasive Glaucoma Surgery (MIGS) Devices Market is Growing With the CAGR of 32.5% in the Forecast Period of 2020 to 2027

Europe Micro Invasive Glaucoma Surgery (MIGS) Devices Market is growing with factors such as high prevalence of glaucoma across the world and rising geriatric population. The growing popularity of micro invasive surgery devices market in Europe also acts as a major factor for the growth of the market. Technological advancement has also boosted the Europe micro invasive glaucoma surgery (MIGS) devices market. However, inadequate reimbursement scenario decreased the demand of the market.

Micro Invasive Glaucoma Surgery (MIGS) Devices Market Scenario        

According to Data Bridge Market Research, the market for Europe micro invasive glaucoma surgery (MIGS) devices in Germany has the highest market share followed by France and U.K. Market leader Glaukos Corporation which accounts an estimated market share of approximately 36.6% in the European market. The company has gained outstanding sale by providing advanced micro invasive glaucoma surgery (MIGS) devices.

  • In November 2019, Glaukos Corporation announced the acquisition of Avedro, Inc., which also works in the development of products for corneal health. This acquisition has led to widening of product portfolio. Also, the revenue generation of the company is more in the market.

Europe Micro Invasive Glaucoma Surgery (MIGS) Devices MarketTrends Impacting the Market

Now the question is which other regions Glaukos Corporation, Allergan, Ivantis, Inc, Ellex, and Alcon are targeting? Data Bridge Market Research has forecasted a large growth in Germany micro invasive glaucoma surgery (MIGS) devices market and the market leaders targeting France and U.K to be their next pocket revenue for 2020.

Europe micro invasive glaucoma surgery (MIGS) devices market is becoming more competitive with companies such as Glaukos Corporation, Allergan, Ivantis, Inc, Ellex, and Alcon. These are the top dominating companies in micro invasive glaucoma surgery (MIGS) devices market. Data Bridge Market Research new reports highlight the major growth factors and opportunities in the Europe micro invasive glaucoma surgery (MIGS) devices market.

For more analysis on the Europe micro invasive market request for a briefing with our analysts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=europe-micro-invasive-glaucoma-surgery-migs-devices-market

Micro Invasive Glaucoma Surgery (MIGS) Devices Market Development

  • In April 2020, Allergan announced that China's National Medical Products Administration (NMPA) approved the registration of Allergan's XEN Gel Stent for the patients suffering from refractory glaucoma. As this is the first product to get the approval in China, which will lead to increased revenue generation in the market.

Scope of the Micro Invasive Glaucoma Surgery (MIGS) Devices Market

Europe micro invasive glaucoma surgery (MIGS) devices market on the basis of countries into Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland and Rest of Europe.

  • Europe micro invasive glaucoma surgery (MIGS) devices market is further analyzed based on maximum granularity into further segmentation. On the basis of product, Europe micro invasive glaucoma surgery (MIGS) devices market is segmented into MIGS stents, MIGS shunts, vasodialtion devices, filtration devices and surgical system. On the basis of target, Europe micro invasive glaucoma surgery (MIGS) devices market is segmented into trabecular meshwork, suprachoroidal space, subconjunctival filtration and reducing aqueous production. On the basis of surgery type, Europe micro invasive glaucoma surgery (MIGS) devices market is segmented into glaucoma in conjunction with cataract and stand-alone glaucoma. Glaucoma in conjunction with cataract and stand-alone glaucoma is further segmented into MIGS stents, MIGS shunts, vasodialtion devices, filtration devices and surgical system. On the basis of end user, Europe micro invasive glaucoma surgery (MIGS) devices market is segmented into hospital outpatient departments (HOPD), ophthalmology clinics, ambulatory surgery centers (ASCS) and others. On the basis of glaucoma type, Europe micro invasive glaucoma surgery (MIGS) devices market is segmented into open angle glaucoma, acute angle closure glaucoma, secondary glaucoma, normal tension glaucoma. On the basis of material type, Europe micro invasive glaucoma surgery (MIGS) devices market is segmented into titanium, stainless steel, polyamide, gelatin, silicone. On the basis of distribution channel, Europe micro invasive glaucoma surgery (MIGS) devices market is segmented into direct tender and retail sales.

To know more about the study https://www.databridgemarketresearch.com/reports/europe-micro-invasive-glaucoma-surgery-migs-devices-market

Key Pointers Covered in Micro Invasive Glaucoma Surgery (MIGS) Devices Market Industry Trends and Forecast to 2027

  • Market Size
  • Top to Bottom Market Analysis
  • Recent Developments for Market Competitors
  • Recent Market Value for Different Countries
  • Market value and over view of micro invasive glaucoma surgery (MIGS) devices market
  • Company profiling of top eight players of micro invasive glaucoma surgery (MIGS) devices market

Key Market Competitors Covered in the Report

  • Glaukos Corporation
  • Allergan
  • Ivantis, Inc.
  • Ellex (Nova Eye Medical)
  • Alcon
  • BVI
  • Johnson and Johnson Surgical Vision, Inc.
  • MicroSurgical Technology
  • MOLTENO Ophthalmic Ltd
  • New World Medical, Inc.
  • Santen Pharmaceutical Co., Ltd.
  • Sight Sciences

Above are the key players covered in the report, to know about more and exhaustive list of micro invasive glaucoma surgery (MIGS) devices companies’, contact us https://www.databridgemarketresearch.com/toc/?dbmr=europe-micro-invasive-glaucoma-surgery-migs-devices-market

Research Methodology: Micro Invasive Glaucoma Surgery (MIGS) Devices Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis and vendor share analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

  • Demand Side: Dermatologists, Doctors, Healthcare Professionals
  • Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Related Reports

Browse in Healthcare Category Related Reports@ https://www.databridgemarketresearch.com/report-category/healthcare/